ON May 30th, surrounded by patients and their families, President Donald Trump signed into law the spectacularly misnamed “right to try” legislation. The new law appears to offer terminally ill patients the right to get experimental new drugs that might save their lives. In fact, it does no such thing. Sitting at his desk in the Oval Office, pen in hand, Mr Trump predicted it would save “hundreds of thousands” of lives. It will not do that either.
The main point of right-to-try laws is to cut the Food and Drug Administration (FDA) out of the picture when terminally ill patients want access to an unproven medicine. The FDA is already fairly gung-ho about providing this. It receives about 1,000 applications a year and approves all but 1%. The agency makes sure there is sound science behind the request, and no obvious indication that the medicine would harm the patient. Sometimes its drug experts are able to recommend better ways of getting the treatment.
Thankfully these...Continue reading
from United States https://ift.tt/2sS3yJk
via https://ifttt.com/ IFTTT
No comments:
Post a Comment